Timothy Spicer

Skip to main content All experts

RES PROF

SR-RESEARCH DEPARTMENTS

Orcid identifier0000-0002-9080-4226 (opens in a new tab)⁠

RES PROF
SR-RESEARCH DEPARTMENTS

spicert@ufl.edu (opens in a new tab)

sort by:

GRANT
Lexicon GPR75 Cell-Based Nano-Glo Assay Lead Op Support Proposal with 1 Orthogonal Assay
Lexicon Pharmaceuticals10 Apr 2026 - 9 Apr 2027
Active
GRANT
Identification of approved drugs for BDNF insufficiency
National Institute of Health Ninds16 Mar 2026 - 28 Feb 2031
Active
GRANT
Pharmacological targeting of nascent modulators of opioid signaling
National Institute of Health Nida20 Oct 2025 - 31 Jul 2029
Active
GRANT
Reprogramming Cancer: A Paradigm Shift in Oncology Treatment
Florida Department of Health30 Sep 2025 - 30 Jun 2026
Expired
GRANT
High-throughput Organoid Screening Platform for Investigating Novel Traumatic Brain Injury Therapeutics
US Army Med Research Acquisition25 Sep 2025 - 3 Jan 2026
Expired
GRANT
Lexicon oGPCR Cell-Based AG NanoGlo Assay 640K HTS Proprosal with 2 Counterscreens
Lexicon Pharmaceuticals16 Jun 2025 - 11 Jun 2026
Expired
GRANT
Identifying phosphoribosylformylglycinamidine synthase inhibitors as a new class of purine antimetabolites
National Institute of Health Nci7 May 2025 - 28 Feb 2027
Active
GRANT
Amgen Cell-Based Degrader HiBit NanoGlo Assay 50K Pilot HTS
Amgen Inc1 May 2025 - 30 Apr 2026
Expired
GRANT
Utilizing UF's High-throughput Screening Capacities
Takeda Pharmaceutical Company Limited13 Sep 2024 - 31 Mar 2025
Expired
GRANT
Pharmacological targeting of nascent modulators of opioid signaling
National Institute of Health Nida30 Aug 2024 - 31 Jul 2029
Active
GRANT
High Throughput Screening to Discover Bacterial DNA Gyrase Poisoning Inhibitors
National Institute of Health Ncats26 Jul 2024 - 30 Jun 2025
Expired
GRANT
The Cathy D. Perry Trust, Advancing Precision Medicine: Integrating Laser Ablation and High throughput Screening for Personalized Therapeutics in Brain Tumor Treatment
Ocala Royal Dames for Cancer Research2 Jun 2024 - 30 Jun 2026
Expired
GRANT
BioRaptr Replacement Dispensers to Support High Throughput Screening
National Institute of Health Od29 Apr 2024 - 30 Apr 2025
Expired
GRANT
An Innovative Approach to Identify Correctors of Metabolic Complications in HIV
National Institute of Health Niddk20 Mar 2024 - 30 Nov 2028
Active
GRANT
Altos HTS Discovery for ISR Inhibitors 640K HTS with 1 counterscreen
Altos Labs27 Oct 2023 - 26 Apr 2024
Expired
GRANT
TCAL USP11 Biochemcial FRET INH Assay 640K HTS Proprosal with 2 Counterscreens
Takeda Pharm North America20 Oct 2023 - 14 Apr 2024
Expired
GRANT
Arvinas: Ataxin-2 Degraders HiBit cell based 665K HTS with 2 counterscreens
Arvinas Operations20 Jul 2023 - 9 Jul 2024
Expired
GRANT
Drug Discovery for First-In-Class Myosin 10 Inhibitors as a Novel Target for Glioblastoma
National Institute of Health Ninds20 Jun 2023 - 31 Mar 2025
Expired
GRANT
TCAL TREM-2
Takeda Pharm North America6 May 2023 - 31 Oct 2023
Expired
GRANT
Lilly NPY2R AG TR-FRET cAMP High Throughput Screen Assay 880K HTS Proposal with 1 Counterscreen
Science Exchange18 Apr 2023 - 31 Oct 2023
Expired
GRANT
Annexon Bio -Complement C1s Protease Fluorescence INH HTS Campaign with UF Scripps 640K Deck plus 1 Counterscreen
Annexon25 Jan 2023 - 24 Jan 2024
Expired
GRANT
Kainomyx -PfMyo-A Absorbance INH HTS Campaign with UF Scripps 640K Deck plus 1 Counterscreen
Kainomyx1 Dec 2022 - 30 Nov 2023
Expired
GRANT
TCAL OMA-1 FRET Biochemical INH Assay 666K SDDL HTS Proposal with 1 Counterscreen
Takeda Pharm North America29 Nov 2022 - 31 Dec 2023
Expired
GRANT
An Innovative Approach to Identify Correctors of Metabolic Complications in HIV
National Institute of Health Niddk2 Nov 2022 - 31 Aug 2023
Expired
GRANT
Identification of small molecules for neurological complications of HIV and substance abuse comorbidity
National Institute of Health Nida2 Nov 2022 - 31 Jul 2024
Expired

GRANTS